Tech News
← Home  ·  All topics

Medicine

19 GoKawiil briefs on this topic

Opinion Piece Argues AI Is Already Delivering Major Benefits Across Medicine and Business

A published opinion column contends that artificial intelligence is already producing significant real-world benefits, citing its role in saving lives within medicine and boosting productivity in business. The author further argues that, contrary to widespread fears, AI has not yet caused substantial job losses.

Study probes why 10-15% of patients don't lose weight on GLP-1 drugs

Researchers report that while most people on GLP-1 obesity drugs lose about a quarter of their body weight, 10-15% see minimal or no weight loss, according to endocrinologist Daniel Drucker of the University of Toronto. The Endocrine Society has called understanding this variation a research priority, citing early findings that biological sex, genetics and behavioral factors may all play a role, with women consistently losing more weight than men in trials and real-world data.

Stanford study finds brain develops from two distinct stem cell lineages

Stanford School of Medicine researchers report that the human brain forms from two separate types of stem cells rather than one uniform source. One lineage, marked by the Otx2 gene, produces the midbrain and forebrain responsible for higher-order thinking and speech, while a distinct stem cell type gives rise to the hindbrain, which governs basic functions like heartbeat and breathing. Researcher Kyle Loh says this finding allows scientists to grow hindbrain neurons in a lab dish for the first time.

Nature Index report outlines barriers facing regenerative medicine field

A Nature Index 2026 feature on regenerative medicine reviews progress in cell therapy and tissue engineering, including the use of induced pluripotent stem cells (iPSCs) to pursue treatments for autoimmune diseases, Parkinson's disease and heart failure. It also notes clinical trials using stem-cell transplants to replace insulin-producing cells in people with type 1 diabetes have shown some success.

Regenerative-medicine trials underrepresent women and exclude non-binary participants, study finds

An analysis by researchers including the article's author found that women make up around 41% of participants in cardiovascular disease clinical trials generally, but only 18-20% in regenerative-medicine trials for the same condition. Self-identified non-binary people were largely absent from these studies, according to the 2021 analysis.

Nature Index data shows China narrowing US lead in regenerative medicine research

Nature Index analysis covering 2016-2025 ranks the United States first and China second among the top 10 countries by research Share in regenerative medicine. The data also identifies institutions with the highest proportion of output devoted to the field, led by the University of Cincinnati, and highlights the strongest bilateral country collaborations in the area over the same period.

Stanford study finds forebrain and hindbrain develop from separate embryonic origins

Stanford Medicine researchers discovered that the human brain is actually built from two distinct developmental lineages: a hindbrain system controlling breathing and heartbeat, and a forebrain/midbrain system responsible for higher cognition. The team found these two regions arise from separate progenitor pathways rather than one branching from the other, and used this insight to finally grow functional hindbrain motor neurons from human stem cells in the lab. They also traced this dual-origin pattern back over 550 million years, finding it in chickens, zebrafish, and acorn worms.

Stanford study finds human brain develops from two separate progenitor cells, not one

Researchers led by Kyle Loh at Stanford Medicine discovered that the forebrain and hindbrain arise from distinct progenitor cells rather than a single common origin, contradicting decades of neuroscience theory. The forebrain governs higher cognition like language and abstract thought, while the hindbrain controls vital functions such as heartbeat and breathing. The study, published in Nature Neuroscience, was co-led by graduate students Carolyn Dundes and Rayyan Jokhai.

Stanford study finds human brain forms from two separate progenitor cell types

Researchers led by Kyle Loh at Stanford University found that in mouse and human embryos, the front and back regions of the brain arise from distinct progenitor cells rather than a shared developmental origin. Cells expressing the OTX2 gene generate the forebrain and midbrain, while GBX2-expressing cells produce the hindbrain, a pattern confirmed in both mouse embryos and human cells grown in dishes.

RFK Jr. appoints eight new members to US Preventive Services Task Force

Health Secretary Robert F. Kennedy Jr. named eight new members to the 16-seat US Preventive Services Task Force, the federal panel that grades preventive care services like cancer screenings and statins on an A-to-D scale that determines insurance coverage. The appointments come after Kennedy spent over a year sidelining the panel, canceling meetings and firing two of its leaders earlier this year. Several new appointees share ideological alignment with Kennedy and the Trump administration, including critics of COVID-19 vaccines and gender-affirming care, plus a non-physician health economist.

Past Lives podcast retells the 2,500-year-old Siberian Ice Maiden's final journey

A Past Lives episode reconstructs the story of Asana, a young Scythian priestess whose mummified remains, known as the Siberian Ice Maiden, were found preserved in the Altai Mountains permafrost. The narrative imagines her final days, tracing how illness, a riding accident and her role as a spiritual diviner led her to the high plateau where she died roughly 2,500 years ago. The piece situates her individual story within the broader Scythian nomadic world of the Eurasian steppe.

Insilico's AI-designed lung drug rentosertib shows anti-aging signals in trial

Insilico Medicine's AI-designed drug rentosertib, originally developed to treat idiopathic pulmonary fibrosis, produced unexpected reductions in biological age markers during a phase 2a trial. Researchers reanalyzed blood samples from 42 of 71 Chinese trial participants using six computational aging clocks, finding treated patients showed younger predicted ages after 12 weeks compared to placebo recipients.